羟基喜树碱联合干扰素、羟基脲对预防慢性粒细胞性白血病急变的效果观察
出处
《医药论坛杂志》
2010年第21期160-162,共3页
Journal of Medical Forum
参考文献5
-
1Sawyers CL, Shah NP, Kantarijian HM, et al. A phase 1 study of BMS - 354825 in patients with imatinib - resistant and intolerant chronic phase chronicmyeloid leu- kemia (CML)[J]. J. Clin Oncol, 2005,23 (64s) : 6520.
-
2orien S, Kantarjin H, Koller C, et al. Se - quential hemoharringtonine and interfer - on - alpha in the treatment- of early chronic phase chronic mylogenous leukemia [J]. Blood, 1999,93 (12) :4149-4153.
-
3申徐良,魏武,张斌严,张梅香,张国香,杨建斌,梁莉.高三尖杉酯碱为主治疗慢性粒细胞白血病的临床研究[J].长治医学院学报,2006,20(2):102-103. 被引量:3
-
4孟凡义,孙竞,刘启发,徐丹,杨龙江,宋兰林,刘晓力,徐兵,周淑芸.格列卫治疗慢性粒细胞白血病Ph染色体转阴后进行自体外周血干细胞移植的结果[J].第一军医大学学报,2003,23(12):1301-1302. 被引量:8
-
5Deininger M, Buchdunger E, Druker BJ. The development of imatinib as a therapeutic agent for chronic myeloid leukemia [ J ]. Blood, 2005,105 ( 7 ) :2640-2653.
二级参考文献5
-
1[4]Kantarjian HM, Cortes JEO, Brien S, et al. Imatinib mesylate therapy in newly diagnosed patients with Philadelphia chromosomepositive chronic myelogenous leukemia: high incidence of early complete and major cytogenetic response [ J ]. Blood, 2003, 101 (1):97-100.孟凡义,郑维扬,刘晓力,等.ST1 571治疗慢性粒细胞白血病的初步观察[J].第一军医大学学报,2001,21(12):908-11.Meng FY, Zheng WY, Liu XL, et al. ST1 571 for treating 19 patients with chronic-phase chronic myeloid leukemia [J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2001, 21(12): 908-11.
-
2Talpaz M,Kantarjian HM,Paqutte R,et al.A phase 1 study of BMS-354825 in patients with imatinib-resistant and intolerant chronic phase chronic myeloid leukemia (CML).J Clin Oncol,2005,23:64s.
-
3Deininger M,Buchdunger E,Druker BJ.The development of imatinib as a therapeutic agent for chronic myeloid leukemia.Blood,2005,105:2 640~ 2 653.
-
4O'Brien Sm,Kantarjin H,Keating M,et al.Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phase.Blood,1995,86:3322~3326.
-
5O'Brien S,Kantarjin H,koller C,et al.Sequential homoharringtonine and interferon-alpha in the treatment of early chroinc phase chronic my-elogenous leukemia.Blood,1999,4149~4153.
共引文献9
-
1孟凡义.分子信号传导靶点阻断剂治疗慢性粒细胞白血病应注意的问题[J].中华医学杂志,2005,85(16):1082-1084. 被引量:4
-
2李澄宇,孟凡义.CD34阳性慢性粒细胞白血病细胞生物学特征及其意义[J].国外医学(输血及血液学分册),2005,28(5):403-405.
-
3孟凡义.融合基因蛋白靶点药物——依马替尼治疗恶性血液病的临床研究[J].中国实用内科杂志:临床前沿版,2006,26(3):472-475. 被引量:1
-
4侯彩妍,李渤涛.1例格列卫治疗慢性粒细胞白血病发生心包胸腔积液病人的护理[J].护理研究(上旬版),2007,21(9):2342-2342.
-
5李澄宇,孟凡义,孙启鑫,扶云碧,李利,易正山,宋兰林.STI571、三氧化二砷和Velcade对bcr/abl^+-CD34^+细胞增殖、凋亡的影响[J].南方医科大学学报,2007,27(11):1665-1669. 被引量:2
-
6林丽娥,姚红霞,吴从明,姚志明,王晗,王华.格列卫联合化疗治疗31例慢性粒细胞白血病的临床观察[J].临床血液学杂志,2008,21(3):273-274. 被引量:3
-
7韩洁,赵杰宏.内生真菌gyzy-20生产高三尖杉酯碱的成分分析及条件优化[J].安徽农业科学,2010,38(34):19291-19293. 被引量:1
-
8田怀平,王芳,陶荣,杨萍,张健.高三尖杉酯碱治疗慢性粒细胞性白血病的系统评价[J].世界临床药物,2015,36(1):19-25. 被引量:7
-
9李娥,寇雪琴.甲磺酸伊马替尼治疗慢性粒细胞白血病不良反应的观察与对策[J].中国美容医学,2012,21(12X):373-373. 被引量:3
-
1范小红.T细胞淋巴瘤伴糖尿病一例分析[J].中国卫生产业,2012,9(7):138-138.
-
2田宁,张培彤.中性粒细胞增多与恶性肿瘤进展及转移关系的研究[J].中国肿瘤,2010,19(7):470-476. 被引量:6
-
3陈海飞,吴天勤,胡佳乐,唐杰庆,沈红石,李征洋,金玲娟,朱晶晶.沙利度胺联合地塞米松治疗老年多发性骨髓瘤剂量和疗效的关系研究[J].中华血液学杂志,2009,30(10):703-705. 被引量:7
-
4董进梅.羟基脲联合α-干扰素治疗慢性粒细胞白血病132例[J].临床医学,2009,29(1):111-111. 被引量:3
-
5沈宏杰,陈子兴,费敏,祁小飞,岑建农,王元元,何军,姚利,邱桥成.BMI-1基因mRNA与骨髓增生异常综合征进展和预后相关性分析[J].中华血液学杂志,2008,29(8):570-571. 被引量:3
-
6徐燕杰,曹林,王一平,王政民.AgNOR对急性粒细胞白血病疗效判断的价值[J].实用癌症杂志,1993,8(4):196-197. 被引量:1
-
7李玲,钟笛,袁海龙,哈力达·亚森,江明,曲建华,张琼,温丙昭.异基因外周血干细胞移植后外周血出现幼稚粒细胞与白血病复发的关系[J].白血病.淋巴瘤,2008,17(4):271-273.
-
8高炳华,王新生.热疗与慢性粒细胞白血病[J].河北医科大学学报,2010,31(8):1011-1013. 被引量:1
-
9文金全,冯海琳,孙熠,庞菊萍.无脾肿大体征的儿童慢性粒细胞性白血病早期诊断:附3例报告[J].临床儿科杂志,2006,24(4):328-329. 被引量:2
-
10尹列芬,申政磊,姚锦,杨玲,孙丽.慢性粒细胞性白血病患者Cyclin D_1及P16 mRNA表达的研究[J].临床医学,2009,29(10):109-110.